The ROE as of December 2025 (TTM) for Elicio Therapeutics, Inc. (ELTX) is -5657.87%

According to Elicio Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -5657.87%. This represents a change of 2.59% compared to the average of -210.54% of the last 4 quarters.

Elicio Therapeutics, Inc. (ELTX) Historical ROE (quarterly & annually)

How has ELTX ROE performed in the past?

The mean historical ROE of Elicio Therapeutics, Inc. over the last ten years is -12.14%. The current -5657.87% ROE has changed 46.50% with respect to the historical average. Over the past ten years (40 quarters), ELTX's ROE was at its highest in in the June 2024 quarter at 437.59%. The ROE was at its lowest in in the March 2023 quarter at -678.13%.

Elicio Therapeutics, Inc. (ELTX) ROE by Quarter and Year

Discovering the peaks and valleys of Elicio Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Elicio Therapeutics, Inc. (ELTX) Average ROE

How has ELTX ROE performed in the past?

The current ROE of Elicio Therapeutics, Inc. (ELTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Elicio Therapeutics, Inc. (ELTX) ROE vs. Peers

How is ELTX’s ROE compared to its peers?

Elicio Therapeutics, Inc.’s ROE is greater than Applied Therapeutics, Inc. (-65.63%), less than Corbus Pharmaceuticals Holdings, Inc. (-43.65%), less than Molecular Partners AG (-50.31%), greater than Cardiff Oncology, Inc. (-77.23%), less than Rani Therapeutics Holdings, Inc. (3.37%), greater than Milestone Pharmaceuticals Inc. (-1885.07%), greater than PepGen Inc. (-92.51%), less than Nkarta, Inc. (-27.74%), greater than Cassava Sciences, Inc. (-80.34%), greater than Actuate Therapeutics Inc (-2924.50%),

Build a custom stock screener for Elicio Therapeutics, Inc. (ELTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Elicio Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Elicio Therapeutics, Inc. (ELTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Elicio Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.